Document:

EX-10.4

 Exhibit 10.4 

FIGS, INC. 

RESTRICTED STOCK UNIT GRANT NOTICE 

(AMENDED 2016 EQUITY INCENTIVE PLAN) 

Figs, Inc. (the “Company”), pursuant to its Amended 2016 Equity Incentive Plan (the “Plan”), has granted to
Participant (as of the date indicated below) a Restricted Stock Unit Award for the number of shares of the Company’s Common Stock (“RSUs”) set forth below (the “Award”). The Award is subject to
all of the terms and conditions as set forth in this Restricted Stock Unit Grant Notice (this “Grant Notice”) and in the Plan and the Restricted Stock Unit Agreement (the “Agreement”), both of which
are attached hereto and incorporated herein in their entirety. Capitalized terms not otherwise defined herein will have the meanings set forth in the Plan or the Agreement, as applicable. In the event of any conflict between the terms in this Grant
Notice or the Agreement and the Plan, the terms of the Plan will control. 
  

					
			
	Participant:	  	  
	  	
			
	Date of Grant:	  	  
	  	
			
	Vesting Commencement Date:	  	  
	  	
			
	Number of RSUs:	  	  
	  	

  

			
		
	Expiration Date:	  	The Expiration Date for an RSU is the date of termination of Participant’s Continuous Service.
		
	Vesting:	  	Participant will receive a benefit with respect to an RSU only if it vests. Except as explicitly set forth below, two vesting requirements must be satisfied on or before the Expiration Date specified above in order for an RSU to
vest — a time and service-based requirement (the “Service-Based Requirement”) and the “Liquidity Event Requirement” (each set forth below). An RSU will vest (and therefore becomes
a “Vested RSU”) on the first date upon which both the Service-Based Requirement and the Liquidity Event Requirement are satisfied with respect to that particular RSU (the “Vesting
Date”). All RSUs that do not become Vested RSUs on or before the Expiration Date will be immediately forfeited to the Company upon expiration at no cost to the Company.
		
	Service-Based	  	
	Requirement:	  	The Service-Based Requirement will be satisfied in installments as follows: 6.25% of the total number of RSUs will satisfy the Service-Based Requirement on each of the first 16 Quarterly Dates following the Vesting Commencement
Date, subject to Participant’s Continuous Service through each such date. For the avoidance of doubt, upon termination of Participant’s Continuous Service, any RSUs that have yet to become Vested RSUs will be forfeited at no cost to the
Company and Participant will have no further right, title or interest in or to such RSUs or the shares of Common Stock underlying them.
		
		  	“Quarterly Date” means each of March 1, June 1, September 1 and December 1.
		
	Liquidity Event	  	
	Requirement:	  	The Liquidity Event Requirement will be satisfied as to any then-outstanding RSUs on the earliest of the following: (1) the effective date of a registration statement of the Company filed under the Securities Act for the sale
of the Company’s Common Stock or (2) immediately prior to the closing of a Change in Control.

			
	Vesting	  	
	Acceleration:	  	Notwithstanding anything to the contrary in this Grant Notice or the Agreement, if Participant’s Continuous Service terminates for a reason other than Cause or the Participant’s voluntary cessation of Continuous Service
prior to the Liquidity Event Requirement being satisfied, then all of the RSUs for which the Service-Based Requirement has been satisfied will accelerate vesting and become Vested RSUs. In the event of an acceleration of vesting as specified in this
paragraph, the Participant may elect to have shares withheld to satisfy any Tax Related Items (as defined in the Agreement).
		
		  	Further, notwithstanding anything to the contrary in this Grant Notice or the Agreement, if Participant has a Qualifying CIC Termination prior to the second anniversary of the Date of Grant, then 100% of the RSUs that are then
outstanding and unvested will accelerate vesting and become Vested RSUs (it being understood that forfeiture of any unvested RSUs due to termination of Continuous Service will be tolled to the extent necessary to effectuate the vesting acceleration
contemplated by this paragraph).
		
		  	Further, notwithstanding anything to the contrary in this Grant Notice or the Agreement, if a Change in Control occurs on or after the second anniversary of the Date of Grant, then, provided Participant remains in Continuous Service
through immediately prior to the Change in Control, 100% of the RSUs that are then outstanding and unvested will accelerate vesting and become Vested RSUs immediately prior to the Change in Control.
		
		  	For the avoidance of doubt, no more than 100% of the total RSUs may become Vested RSUs.
		
		  	“Employment Agreement” means that certain Employment Agreement by and between the Company and
                     dated
                    .
		
		  	“Qualifying CIC Termination” means a termination of Participant’s Continuous Service either (1) by the Company or one of its Affiliates (or a successor of the Company or an Affiliate of the Company)
other than for death, disability, or Cause (as defined in the Employment Agreement) or (2) by Participant for Good Reason (as defined in the Employment Agreement), in each case, during the period beginning on the date that is three
(3) months prior to the effective date of a Change in Control and ending on the date that is twelve (12) months after the effective date of a Change in Control.
		
	Settlement:	  	If an RSU vests as provided for above, the Company will issue one share of Common Stock for each Vested RSU. The shares will be issued in accordance with the issuance schedule set forth in Section 5 of the Agreement.

 Additional Terms/Acknowledgements: Participant acknowledges receipt of, and understands and agrees to, this
Grant Notice, the Agreement and the Plan. Participant further acknowledges that as of the Date of Grant, this Grant Notice, the Agreement and the Plan set forth the entire understanding between Participant and the Company regarding this Award and
supersede all prior oral and written agreements, offer letters, promises and/or representations on that subject with the exception of (1) equity awards previously granted and delivered to Participant, (2) any compensation recovery policy
that is adopted by the Company or is otherwise required by applicable law and (3) any written employment or severance arrangement that would provide for vesting acceleration of this Award upon the terms and conditions set forth therein
(provided that if there is any conflict in the vesting and/or acceleration terms, those contained in this Grant Notice and the Agreement will control). 

  
 2 

 By accepting the Award, Participant acknowledges having received and read the Grant Notice, the Agreement
and the Plan (the “Grant Documents”) and agrees to all of the terms and conditions set forth in these documents. Furthermore, by accepting the Award, Participant consents to receive such documents by electronic delivery and
to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company. 

Notwithstanding the above, if Participant has not actively accepted the Award within 90 days of the Date of Grant set forth in this Grant Notice, Participant
is deemed to have accepted the Award, subject to all of the terms and conditions of the Grant Documents. 
  

									
	FIGS, INC.	 		  	PARTICIPANT:
				
	By:	 	  
	 		  	  

	Signature	 		  	Signature
		 		  	Date:	  	  

	Name & Title:	 	  
	 	
	Date:	 	  
	 		  		  	

 ATTACHMENTS: 
  

	 	•	 	 Attachment I: Restricted Stock Unit Agreement 

 

	 	•	 	 Attachment II: Amended 2016 Equity Incentive Plan 

  
 3 

 ATTACHMENT I 

FIGS, INC. 

RESTRICTED STOCK UNIT AGREEMENT 

(AMENDED 2016 EQUITY INCENTIVE PLAN) 

Pursuant to the Restricted Stock Unit Grant Notice (the “Grant Notice”) and this Restricted Stock Unit Agreement (the
“Agreement”), Figs, Inc. (the “Company”) has granted to you a Restricted Stock Unit Award for the number of shares of the Company’s Common Stock (“RSUs”) indicated in the
Grant Notice (the “Award”) under its Amended 2016 Equity Incentive Plan (the “Plan”). The Award is granted to you effective as of the Date of Grant set forth in the Grant Notice for this Award.
Capitalized terms not explicitly defined in this Agreement will have the same meanings given to them in the Plan or Grant Notice, as applicable. The terms and conditions of the Award, in addition to those set forth in the Grant Notice and the Plan,
are as follows. 
 1. NATURE OF THE AWARD. The Award represents the right
to be issued on a future date the number of shares of the Company’s Common Stock as indicated in the Grant Notice upon the satisfaction of the terms set forth in this Agreement. Except as otherwise provided herein, you will not be
required to make any payment to the Company with respect to your receipt of the Award, the vesting of the RSUs or the issuance of the underlying shares of Common Stock. 

2. VESTING. Subject to the limitations contained herein, the Award will vest in accordance with the vesting
schedule provided in the Grant Notice. Upon termination of your Continuous Service, any RSUs that have yet to satisfy any time and service-based requirement, including the Service-Based Requirement, will be forfeited at no cost to the Company and
you will have no further right, title or interest in or to such RSUs or the shares of Common Stock covered thereby. 
 3.
NUMBER OF SHARES. 
 (a) The number of RSUs subject to the Award will be adjusted
from time to time for Capitalization Adjustments, as provided in the Plan. 
 (b) Any additional RSUs, shares, cash or other property
that become subject to the Award pursuant to this Section 3, if any, will be subject, in a manner determined by the Board, to the same forfeiture restrictions, restrictions on transferability, and time and manner of issuance as applicable to
the other shares covered by the Award. 
 (c) Notwithstanding the provisions of this Section 3, no fractional shares or rights
for fractional shares of Common Stock will be created pursuant to this Section 3. The Board will, in its sole discretion, determine an equivalent benefit for any fractional shares or fractional shares that might be created by the adjustments
referred to in this Section 3. 
 4. SECURITIES LAW AND OTHER
COMPLIANCE. You may not be issued any shares under the Award unless either (a) the shares are registered under the Securities Act; or (b) the Company has determined that such issuance would be exempt from the
registration requirements of the Securities Act. The Award also must comply with other applicable laws and regulations governing the Award, and you will not receive such shares if the Company determines that such receipt would not be in material
compliance with such laws and regulations. 

 5. DATE OF ISSUANCE. 

(a) Subject to the satisfaction of the Tax-Related Items set forth in Section 11 of this
Agreement, in the event one or more RSUs vest, the Company will issue to you one (1) share of Common Stock for each RSU that vests on the applicable Vesting Date (subject to any adjustment under Section 3 above) (such date, the
“Original Issuance Date”). 
 (b) If the Original Issuance Date falls on a date that is not a business day,
issuance will instead occur on the next following business day. In addition, to the extent applicable at a Vesting Date when the Common Stock is registered under the Securities Act, if: 

(i) the Original Issuance Date does not occur (1) during an “open window period” applicable to you, as determined by the
Company in accordance with the Company’s then-effective policy on trading in Company securities, or (2) on a date when you are otherwise permitted to sell shares of Common Stock on an established stock exchange or stock market (including
but not limited to under a previously established written trading plan that meets the requirements of Rule 10b5-1 under the Exchange Act and was entered into in compliance with the Company’s policies (a
“10b5-1 Arrangement”)), and 
 (ii) either (1) no Tax-Related Items apply, or (2) the Company decides, prior to the Original Issuance Date, (A) not to satisfy the Tax-Related Items by withholding shares of Common
Stock from the shares of Common Stock otherwise due, on the Original Issuance Date, to you under this Award, and (B) not to permit you to enter into a “same day sale” commitment with a broker-dealer pursuant to Section 11 of this
Agreement (including but not limited to a commitment under a 10b5-1 Arrangement) and (C) not to permit you to pay the Tax-Related Items in cash, 

then the shares of Common Stock that would otherwise be issued to you on the Original Issuance Date will not be issued on such Original
Issuance Date and will instead be issued on the first business day when you are not prohibited from selling shares of Common Stock in the open public market, but in no event later than (a) December 31 of the calendar year in which the
Original Issuance Date occurs (that is, the last day of your taxable year in which the Original Issuance Date occurs), or (b) if and only if permitted in a manner that complies with Treasury Regulations
Section 1.409A-1(b)(4), the date that is the 15th day of the third calendar month of the year immediately following the year in which the shares of Common Stock covered by this Award are no longer subject
to a “substantial risk of forfeiture” within the meaning of Treasury Regulations Section 1.409A-1(d). 

(c) The form of such issuance (e.g., a stock certificate or electronic entry evidencing such shares of Common Stock) will be
determined by the Company. In all cases, the issuance of shares under this Award is intended to comply with Treasury Regulations Section 1.409A-1(b)(4) and will be construed and administered in such a
manner. 
 6. DIVIDENDS. You will receive no benefit or adjustment to your RSUs with respect to any cash
dividend, stock dividend or other distribution except as provided in the Plan with respect to a Capitalization Adjustment. 
 7.
LOCK-UP PERIOD. By acquiring shares of Common Stock under your Award, you agree that you will not sell, dispose of, transfer, make any short sale of, grant any option for the
purchase of, or enter into any hedging or similar transaction with the same economic effect as a sale with respect to, any shares of Common Stock or other securities of the Company held by you, for a period of one hundred eighty (180) days following
the effective date of a registration statement of the Company filed under the Securities Act or such longer period as the underwriters or the Company will request to facilitate compliance with FINRA Rule 2241 or any successor or similar rule or
regulation (the “Lock-Up Period”); provided, 

  
 2 

 
however, that nothing contained in this Section 7 will prevent the exercise of a repurchase option, if any, in favor of the Company during the
Lock-Up Period. You further agree to execute and deliver such other agreements as may be reasonably requested by the Company or the underwriters that are consistent with the foregoing or that are necessary to
give further effect thereto. In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect to your shares of Common Stock until the end of such period. You also agree that any transferee of any shares of
Common Stock or other securities of the Company held by you will be bound by this Section 7. The underwriters of the Company’s stock are intended third party beneficiaries of this Section 7 and will have the right, power and authority
to enforce the provisions of this Section 7 as though they were a party to this Agreement. 
 8. TRANSFER
RESTRICTIONS. Shares of Common Stock that you acquire upon vesting and settlement of your Award are subject to any restrictions on transfer and/or right of first refusal that may be set forth in the Company’s bylaws in
effect at such time the Company elects to exercise its right. In addition to any other limitation on transfer created by applicable securities laws, you will not sell, assign, hypothecate, donate, encumber or otherwise dispose of all or any part of
the shares subject to your Award or any interest in such shares, whether voluntarily or by operation of law, by gift, by entering into a contract that requires shares to be issued at a future date, or otherwise, except in compliance with this
Agreement, the Company’s bylaws and applicable securities law. 
 9. RESTRICTIVE LEGENDS. The
shares of Common Stock issued in respect of your Award will be endorsed with appropriate legends as determined by the Company. 

10. AWARD NOT AN EMPLOYMENT OR SERVICE
CONTRACT. 
 (a) Subject to applicable law, your employment or other service with the Company or any Affiliate is
not for any specified term and may be terminated by you or by the Company or an Affiliate at any time, for any reason, with or without cause and with or without notice. Nothing in this Agreement (including, but not limited to, the vesting of the
Award pursuant to Section 2 or the issuance of the shares subject to the Award), the Plan or any covenant of good faith and fair dealing that may be found implicit in this Agreement or the Plan will: (i) confer upon you any right to
continue in the employ of, or affiliation with, the Company or an Affiliate; (ii) constitute any promise or commitment by the Company or an Affiliate regarding the fact or nature of future positions, future work assignments, future compensation
or any other term or condition of employment or affiliation; (iii) confer any right or benefit under this Agreement or the Plan unless such right or benefit has specifically accrued under the terms of this Agreement or Plan; or
(iv) deprive the Company or an Affiliate of the right to terminate your employment or engagement at will (subject to applicable law) and without regard to any future vesting opportunity that you may have. 

(b) By accepting this Award, you acknowledge and agree that the right to continue vesting in the Award pursuant to Section 2 and
the schedule set forth in the Grant Notice is earned only by continuing as an employee, director or consultant at the will of the Company or an Affiliate (not through the act of being hired, being granted this Award or any other award or benefit)
and that the Company has the right to reorganize, sell, spin-out or otherwise restructure one or more of its businesses or Affiliates at any time or from time to time, as it deems appropriate (a
“reorganization”). You further acknowledge and agree that such reorganization could result in the termination of your Continuous Service, or the termination of Affiliate status of your employer and the loss of benefits
available to you under this Agreement, including but not limited to, the termination of the right to continue vesting in the Award. 

  
 3 

 11. RESPONSIBILITY FOR TAXES. 

(a) You acknowledge that, regardless of any action taken by the Company, the ultimate liability for all income tax (including U.S.
federal, state, and local taxes and/or non-U.S. taxes), social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to your
participation in the Plan and legally applicable to you or deemed by the Company in its sole discretion to be an appropriate charge to you even if legally applicable to the Company (“Tax-Related
Items”) is and remains your responsibility and may exceed the amount actually withheld by the Company. 
 (b) Prior to
any relevant taxable or tax withholding event, as applicable, you agree to make adequate arrangements satisfactory to the Company and/or your employer (if not the Company) to satisfy all Tax-Related Items. In
this regard, you authorize the Company or its agent to satisfy their withholding obligations with regard to all Tax-Related Items, if any, by any of the following methods or by a combination of such methods:
(i) withholding from any compensation otherwise payable to you by the Company or your employer; (ii) causing you to tender a cash payment; (iii) entering on your behalf (pursuant to this authorization without further consent) into a
“same day sale” commitment with a broker dealer that is a member of the Financial Industry Regulatory Authority (a “FINRA Dealer”) whereby you irrevocably elect to sell a portion of the shares to be issued under the
Award to satisfy the Tax-Related Items and whereby the FINRA Dealer irrevocably commits to forward the proceeds necessary to satisfy the Tax-Related Items directly to
the Company and/or its Affiliates; (iv) withholding shares of Common Stock from the shares of Common Stock issued or otherwise issuable to you in connection with the Award with a Fair Market Value (measured as of the date the applicable shares
of Common Stock are issued to you or, if and as determined by the Company, the date on which the Tax-Related Items are required to be calculated) equal to the amount of such
Tax-Related Items; or (v) any other method of withholding determined by the Company and permitted by applicable law. The Company will use commercially reasonable efforts (as determined by the Company in
its sole discretion) to facilitate the satisfaction of Tax-Related Items by you using one of the methods described in clauses (iii) and (iv) of the preceding sentence or by permitting you to sell shares
of Common Stock in any initial public offering by the Company. However, the Company does not guarantee that you will be able to satisfy any Tax-Related Items through any of the methods described in the
preceding sentence and in all circumstances you remain responsible for timely and fully satisfying the Tax-Related Items. Depending on the withholding method used, the Company may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding rates or other applicable withholding rates, including up to the maximum applicable rate in your jurisdiction to the extent permitted under
the Plan, in which case you may receive a refund of any over-withheld amount in cash and will have no entitlement to the equivalent in shares of Common Stock. In the event any under-withholding results from the application of minimum statutory or
other withholding rates, you may be required to pay additional amounts to the tax authorities. If the obligation for Tax-Related Items is satisfied by withholding in shares of Common Stock, for tax purposes,
you are deemed to have been issued the full number of shares of Common Stock subject to the vested portion of the Award, notwithstanding that a number of the shares of Common Stock are held back solely for the purpose of paying the Tax-Related Items. 
 (c) Finally, you agree to pay to the Company or your employer any amount of Tax-Related Items that the Company or your employer may be required to withhold or account for as a result of your participation in the Plan that cannot be satisfied by any of the withholding methods previously
described. Notwithstanding any contrary provision of the Plan, the Grant Notice or this Agreement, if you fail to make satisfactory arrangements for the payment of any Tax-Related Items when due, you
permanently will forfeit the RSUs on which the Tax-Related Items were not satisfied and will also permanently forfeit any right to receive shares of Common Stock thereunder. In that case, the RSUs will be
returned to the Plan at no cost to the Company. 

  
 4 

 12. INVESTMENT REPRESENTATIONS. In connection with your
receipt of the Award and the Common Stock under your Award, you represent to the Company the following: 
 (a) You are aware of
the Company’s business affairs and financial condition and have acquired sufficient information about the Company to reach an informed and knowledgeable decision to acquire the Common Stock. You are acquiring the Common Stock for investment for
your own account only and not with a view to, or for resale in connection with, any “distribution” thereof within the meaning of the Securities Act. 

(b) You understand that the Common Stock has not been registered under the Securities Act by reason of a specific exemption therefrom,
which exemption depends upon, among other things, the bona fide nature of your investment intent as expressed in this Agreement. 
 (c)
You further acknowledge and understand that the Common Stock must be held indefinitely unless the Common Stock is subsequently registered under the Securities Act or an exemption from such registration is available. You further acknowledge and
understand that the Company is under no obligation to register the Common Stock. You understand that the certificate evidencing the Common Stock will be imprinted with a legend that prohibits the transfer of the Common Stock unless the Common Stock
is registered or such registration is not required in the opinion of counsel for the Company. 
 (d) You are familiar with the
provisions of Rules 144 and 701 under the Securities Act, as in effect from time to time, which, in substance, permit limited public resale of “restricted securities” acquired, directly or indirectly, from the issuer thereof (or from an
affiliate of such issuer), in a non-public offering subject to the satisfaction of certain conditions. Rule 701 provides that if the issuer qualifies under Rule 701 at the time of issuance of the securities,
such issuance will be exempt from registration under the Securities Act. In the event the Company becomes subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act, the securities exempt under Rule 701 may be sold by you
90 days thereafter, subject to the satisfaction of certain of the conditions specified by Rule 144 and the Lock-Up Period agreement described in Section 7. 

(e) In the event that the sale of the Common Stock does not qualify under Rule 701 at the time of issuance, then the Common Stock may be
resold by you in certain limited circumstances subject to the provisions of Rule 144, which requires, among other things: (i) the availability of certain public information about the Company; and (ii) the resale occurring following the
required holding period under Rule 144 after you have purchased, and made full payment of (within the meaning of Rule 144), the securities to be sold. 

(f) You further understand that at the time you wish to sell the Common Stock there may be no public market upon which to make such a
sale, and that, even if such a public market then exists, the Company may not be satisfying the current public information requirements of Rule 144 or 701, and that, in such event, you would be precluded from selling the Common Stock under Rule 144
or 701 even if the minimum holding period requirement had been satisfied. 
 13. NO OBLIGATION
TO MINIMIZE TAXES. You acknowledge that the Company is not making representations or undertakings regarding the treatment of any Tax-Related Items in
connection with any aspect of the Award, including, but not limited to, the grant, vesting or settlement of the Award, the subsequent sale of shares of Common Stock acquired pursuant to such settlement and the receipt of any dividends and/or any
dividend equivalent payments. Further, you acknowledge that the Company does not have any duty or obligation to minimize your liability for Tax-Related Items arising from the Award or to achieve any particular
tax result and will not be liable to you for any Tax-Related Items arising in connection with the Award. If you become subject to taxation in more than one jurisdiction, the Company and/or your employer (or
former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction. 

  
 5 

 14. NO ADVICE REGARDING
GRANT. The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding your participation in the Plan, or your acquisition or sale of the underlying shares of Common
Stock. You are hereby advised to consult with your own personal tax, financial and/or legal advisors regarding the Tax-Related Items arising in connection with the Award and by accepting the Award, you have
agreed that you have done so or knowingly and voluntarily declined to do so. 
 15. UNSECURED OBLIGATION.
The Award is unfunded, and as a holder of a vested Award, you will be considered an unsecured creditor of the Company with respect to the Company’s obligation, if any, to issue shares pursuant to this Agreement. You will not have
voting or any other rights as a stockholder of the Company with respect to the shares to be issued pursuant to this Agreement until such shares are issued to you pursuant to Section 5 of this Agreement. Upon such issuance, you will obtain full
voting and other rights as a stockholder of the Company. Nothing contained in this Agreement, and no action taken pursuant to its provisions, will create or be construed to create a trust of any kind or a fiduciary relationship between you and the
Company or any other person. 
 16. NOTICES. Any notices provided for in the Grant Notice, this Agreement or the Plan
will be given in writing and will be deemed effectively given upon receipt or, in the case of notices delivered by the Company to you, five (5) days after deposit in the United States mail, postage prepaid, addressed to you at the last
address you provided to the Company. Notwithstanding the foregoing, the Company may, in its sole discretion, decide to deliver any documents related to participation in the Plan and this Award by electronic means or to request your consent to
participate in the Plan by electronic means. You hereby consent to receive such documents by electronic delivery and, if requested, to agree to participate in the Plan through an on-line or electronic system
established and maintained by the Company or a third party designated by the Company. 
 17. MISCELLANEOUS. 

(a) As a condition to the grant of your Award or to the Company’s issuance of any shares of Common Stock under this Agreement, the
Company may require you to execute certain customary agreements entered into with the holders of capital stock of the Company, including without limitation, a right of first refusal and co-sale agreement and a
stockholders agreement. 
 (b) The rights and obligations of the Company under the Award will be transferable to any one or more
persons or entities, and all covenants and agreements hereunder will inure to the benefit of, and be enforceable by, the Company’s successors and assigns. Your rights and obligations under the Award may only be assigned with the prior written
consent of the Company. 
 (c) You agree upon request to execute any further documents or instruments necessary or desirable in the
sole determination of the Company to carry out the purposes or intent of the Award. 
 (d) You acknowledge and agree that you have
reviewed the documents provided to you in relation to the Award in their entirety, have had an opportunity to obtain the advice of counsel prior to executing and accepting the Award, and fully understand all provisions of such documents. 

(e) This Agreement will be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or
national securities exchanges as may be required. 

  
 6 

 (f) All obligations of the Company under the Plan and this Agreement will be binding
on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company. 

(g) The Company reserves the right to impose other requirements on your participation in the Plan, on the Award and on any shares of
Common Stock acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require you to sign any additional agreements or undertakings that may be necessary to accomplish the
foregoing. 
 18. GOVERNING PLAN DOCUMENT. The Award is subject to all the provisions of
the Plan, the provisions of which are hereby made a part of the Award, and is further subject to all interpretations, amendments, rules and regulations which may from time to time be promulgated and adopted pursuant to the Plan. Except as
expressly provided herein, in the event of any conflict between the provisions of the Award and those of the Plan, the provisions of the Plan will control. 

19. SEVERABILITY. If all or any part of this Agreement or the Plan is declared by any court or governmental
authority to be unlawful or invalid, such unlawfulness or invalidity will not invalidate any portion of this Agreement or the Plan not declared to be unlawful or invalid. Any Section of this Agreement (or part of such a Section) so declared to be
unlawful or invalid will, if possible, be construed in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible while remaining lawful and valid. 

20. GOVERNING LAW AND VENUE.
The interpretation, performance and enforcement of this Agreement will be governed by the law of the state of Delaware without regard to such state’s conflict of laws rules. For purposes of litigating any dispute that arises directly
or indirectly from the relationship of the parties evidenced by this grant or the Agreement, the parties hereby submit to and consent to the exclusive jurisdiction of the State of California and agree that such litigation shall be conducted only in
the courts of Los Angeles County, California, or the United States federal courts for the Central District of California, and no other courts, where this grant is made and/or to be performed. 

21. EFFECT ON OTHER EMPLOYEE BENEFIT PLANS.
The value of the Award subject to this Agreement will not be included as compensation, earnings, salaries, or other similar terms used when calculating your benefits under any employee benefit plan sponsored by the Company or any
Affiliate, except as such plan otherwise expressly provides. The Company expressly reserves its rights to amend, modify, or terminate any of the Company’s or any Affiliate’s employee benefit plans. 

22. AMENDMENT. This Agreement may not be modified, amended or terminated except by an instrument in writing,
signed by you and by a duly authorized representative of the Company. Notwithstanding the foregoing, this Agreement may be amended solely by the Board by a writing which specifically states that it is amending this Agreement, so long as a copy of
such amendment is delivered to you, and provided that, except as otherwise expressly provided in the Plan, no such amendment adversely affecting your rights hereunder may be made without your written consent. Without limiting the foregoing, the
Board reserves the right to change, by written notice to you, the provisions of this Agreement in any way it may deem necessary or advisable to carry out the purpose of the grant as a result of any change in applicable laws or regulations or any
future law, regulation, ruling, or judicial decision, provided that any such change will be applicable only to rights relating to that portion of the Award which is then subject to restrictions as provided herein. 

  
 7 

 23. COMPLIANCE WITH SECTION
409A OF THE CODE. This Award is intended to comply with the “short-term deferral” rule set forth in Treasury Regulations Section 1.409A-1(b)(4). Notwithstanding the foregoing, if it is determined that the Award fails to satisfy the requirements of the short-term deferral rule and is otherwise deferred compensation subject to
Section 409A, and if you are a “Specified Employee” (within the meaning set forth Section 409A(a)(2)(B)(i) of the Code) as of the date of your separation from service (within the meaning of Treasury Regulations Section 1.409A-1(h)), then the issuance of any shares that would otherwise be made upon the date of the separation from service or within the first six months thereafter will not be made on the originally
scheduled date(s) and will instead be issued in a lump sum on the date that is six months and one day after the date of the separation from service, with the balance of the shares issued thereafter in accordance with the original vesting and
issuance schedule set forth above, but if and only if such delay in the issuance of the shares is necessary to avoid the imposition of taxation on you in respect of the shares under Section 409A of the Code. Each installment of shares that
vests is intended to constitute a “separate payment” for purposes of Treasury Regulations Section 1.409A-2(b)(2). Notwithstanding any contrary provision of the Plan, the Grant Notice, or of this
Agreement, under no circumstances will the Company reimburse you for any taxes or other costs under Section 409A or any other tax law or rule. All such taxes and costs are solely your responsibility. 

*        *        * 

This Agreement will be deemed to be accepted by you upon the signing (which may be electronic) 

by you of the Restricted Stock Unit Grant Notice to which it is attached or by the deemed 

acceptance of this Agreement, as described in the Restricted Stock Unit Grant Notice. 

  
 8 

 ATTACHMENT II 

AMENDED 2016 EQUITY INCENTIVE PLAN 

 
  

  
 9tptx-ex103_12.htm

Exhibit 10.3

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE TURNING POINT THERAPEUTICS, INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO TURNING POINT THERAPEUTICS, INC. IF PUBLICLY DISCLOSED.

 

Amendment No. 1

to  License Agreement

 

This Amendment No. 1 to License Agreement (this “Amendment No. 1”) is made effective as of March   31, 2021 (the “Amendment Effective Date”), by and between Turning Point Therapeutics, Inc., a corporation organized and existing under the laws of Delaware (“TPTX”) located at 10628 Science Center Drive, Suite 200, San Diego, California 92121, United States of America, and Zai Lab (Shanghai) Co., Ltd., an exempted company organized and existing under the laws of P.R. of China, located at 4F, Bldg 1, Jinchuang Plaza, 4560 Jinke Rd, Shanghai, China, 201210 (“Zai”).  

 

 Whereas, TPTX and Zai are parties to a License Agreement, dated January 10, 2021 (the “Agreement”); and

 

Whereas, TPTX and Zai wish to amend the Agreement as described in this Amendment No. 1. Capitalized terms not defined in this Amendment No. 1 shall have the meaning ascribed such terms in the Agreement.

 

Now, Therefore, TPTX and Zai agree to amend the Agreement as follows:

 

	
 
	
1.
	
The first two sentences of Section 2.7 (TPTX’s Right of First Negotiation) of the Agreement are hereby deleted and replaced in their entirety with the following:

 

“During the [***] month period following the Effective Date, Zai will provide [***]. TPTX will [***], with such notice to be given [***] the “Zai Pipeline Product”).”

 

	
 
	
2.
	
As amended hereby, the terms and conditions of the Agreement remain in full force and effect.

 

	
 
	
3.
	
This Amendment No. 1 may be executed in two or more counterparts, each of which shall be deemed an original, but all of which taken together shall constitute one and the same instrument.  Electronic signatures or signatures on pdf versions of this Amendment No. 1 exchanged via email, shall be deemed original signatures for all purposes.

 

In Witness Whereof, the Parties intending to be bound have caused this Amendment No. 1 to be executed by their duly authorized representatives effective as of the Amendment Effective Date.

		
	
 

Turning Point Therapeutics, Inc.

 

 

By: /s/Athena Countouriotis

 

Name: Athena Countouriotis

 

Title: Chief Executive Officer

 

Date: April 01, 2021

 
	
 

Zai Lab (Shanghai) Co., Ltd.

 

 

By: /s/ Samantha Du

 

Name: Samantha Du

 

Title: CEO and Chairperson

 

Date: April 01, 2021 

 

1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00327-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00327-of-00352.parquet"}]]